Back
Argan, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
62
AGX
Argan, Inc.
Last Price:
$325.56
Seasonality Move:
5.99%
Sell
31
MNPR
Monopar Therapeutics, Inc.
Last Price:
$69.11
Seasonality Move:
25.93%
Buy
62
Argan, Inc. (AGX)
is a Buy
Is Argan, Inc. a Buy, Sell or Hold?
-
The current Argan, Inc. [AGX] share price is $313.90. The Score for AGX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
AGX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
31
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $65.99. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AGX Stock Price Chart
What is Argan, Inc.'s stock price today?
-
The Argan, Inc. share price today is $313.90The current trend is relatively stagnant and AGX is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $65.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
AGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.87 | Sell |
| Relative Strength Index (14 RSI): | 45.27 | Sell |
| Chaikin Money Flow: | 166513 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (318.91 - 366.27) | Sell |
| Bollinger Bands (100): | (232.24 - 329.5) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.42 | Sell |
| Relative Strength Index (14 RSI): | 32.25 | Sell |
| Chaikin Money Flow: | -36886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.08 - 86.32) | Sell |
| Bollinger Bands (100): | (45.17 - 89.09) | Sell |
AGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 319.66 | Sell |
| 20-day SMA: | 341.43 | Sell |
| 50-day SMA: | 321.71 | Sell |
| 200-day SMA: | 228.64 | Buy |
| 8-day EMA: | 318.93 | Sell |
| 20-day EMA: | 329.33 | Sell |
| 50-day EMA: | 317.86 | Sell |
| 200-day EMA: | 244.56 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.2 | Sell |
| 20-day SMA: | 79.37 | Sell |
| 50-day SMA: | 82.12 | Sell |
| 200-day SMA: | 52.13 | Buy |
| 8-day EMA: | 72.25 | Sell |
| 20-day EMA: | 76.67 | Sell |
| 50-day EMA: | 77.13 | Sell |
| 200-day EMA: | 56.56 | Buy |
Argan, Inc. Earnings Growth & AGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.14 per share, an increase this year of $2.73 per share, and an increase next year of $3.30 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Argan, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||